Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

January 19, 2021
Preprint
Open Access

Identifying neuron subtype-specific metabolic network changes in single cell transcriptomics of Alzheimer's Disease using perturb-Met

BioRxiv : the Preprint Server for Biology
Yuliang Wang
January 1, 2021
Preprint
Open Access

Cell type resolved co-expression networks of core clock genes in brain development.

BioRxiv : the Preprint Server for Biology
Soundhar RamasamyA. H. Ansari
December 12, 2020
Open Access

Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale

Cells
Nicolas RuffiniSusanne Gerber
December 17, 2020
Open Access

REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment

International Journal of Molecular Sciences
Jee Hyun YiDong Hyun Kim
December 17, 2020
Review
Open Access

High Mobility Group Box-1 and Blood-Brain Barrier Disruption

Cells
Masahiro NishiboriHidenori Wake
December 12, 2020
Review
Open Access

Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease

Frontiers in Molecular Neuroscience
Bhanu Chandra KarisettyFelice Elefant
January 9, 2021
Preprint
Open Access

Double stranded RNA drives innate immune responses, sickness behavior and cognitive impairment dependent on dsRNA length, IFNAR1 expression and age

BioRxiv : the Preprint Server for Biology
N. McGarryColm Cunningham
December 15, 2020
Open Access

Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model

Neurobiology of Disease
Doris Lambracht-WashingtonRoger N Rosenberg
January 12, 2021
Preprint
Open Access

The three-dimensional landscape of chromatin accessibility in Alzheimer's disease

BioRxiv : the Preprint Server for Biology
J. BendlPanos Roussos
January 15, 2021

A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding

Proceedings of the National Academy of Sciences of the United States of America
Xun SunPeter E Wright
December 16, 2020

Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function

Neuron
Yu YamazakiGuojun Bu
December 29, 2020
Open Access

Unraveling Targetable Systemic and Cell-Type-Specific Molecular Phenotypes of Alzheimer's and Parkinson's Brains With Digital Cytometry

Frontiers in Neuroscience
Marie C Bordone, Nuno L Barbosa-Morais
January 6, 2021
Open Access

Differential transcript usage unravels gene expression alterations in Alzheimer's disease human brains

Npj Aging and Mechanisms of Disease
Diego Marques-CoelhoMarcos Romualdo Costa

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-transcription/59381bb2-c649-4d20-a018-bdc1da706b86